RayzeBio (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- October 14, 2020
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $45,000,000
Company Info
- Founding Year
- 2020
- Founders
- Deborah Charych, Aaron Kantoff, Aron Knickerbocker
- Company Description
- RayzeBio is a biotechnology company that aims to improve clinical benefit by efficiently developing innovative tumor-targeted small molecule medicines that harness the power of radioisotopes. With a focus on clinically validated solid tumor targets, RayzeBio is developing novel macrocyclic peptide mimetic binders to deliver potent therapeutic radioisotopes such as Actinium-225, an alpha-emitter.
- Market
- Healthcare
- Location
- San Diego, CA, USA
- Coinvestors
- Samsara BioCapital, VenBio, Versant Ventures